港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

恒瑞医药

71.700

+0.6000.84%

成交量：156.18万

成交额：1.13亿

市值：4,758.73亿

市盈率：65.56

高：72.600

开：70.900

低：70.700

收：71.100

52周最高：95.200

52周最低：52.500

股本：66.37亿

香港流通股本：2.58亿

量比：1.11

换手率：0.61%

股息：- -

股息率：- -

每股收益(LYR):1.094

净资产收益率：14.34%

总资产收益率：8.37%

市净率：7.31

市盈率(LYR):65.56

市销率: 14.04

数据加载中...

总览公司新闻资讯公告

医药领域，这些潜力赛道即将爆发！

创新药龙头领跑与新锐突围的双重奏｜三季报专题

智通AH统计|11月11日

每日卖空追踪 | 恒瑞医药 11月11日卖空量成交45.76万股，卖空比例为15.94%

透视81家创新药企三季报：亏损收窄医保放量BD增长释放什么信号？

从政策优化到价值发现：医药产业升级下的投资新机遇

宏观经济点评：有色与中下游制造带动PPI同比回升

恒瑞医药(01276)11月10日斥资366.84万元回购6万股A股

每日卖空追踪 | 恒瑞医药 11月10日卖空量成交27.96万股，卖空比例为8.36%

智通AH统计|11月10日

中邮证券-医药生物行业周报：自免口服药物市场存在供需错配，关注NME带来的积极转变-251110

69岁药企“老兵”海正药业再战江湖，跨界医美能否焕发第二春？

报告：全球区域化趋势已基本形成，长三角这项能力需加强

医药行业周报：AI+医疗发展方向落地，2030年实现基层AI诊疗全覆盖

核心50ETF开盘涨0.47%，重仓股东方财富跌0.08%，恒瑞医药跌0.02%

中国创新药“生死局”：一边是IPO，一边是ICU

腾讯新闻潜望

A+H板块持续扩容 AH溢价呈现分化

恒瑞医药：“创新+出海”快速推动全球化

【国投证券 | 医药】医药板块25Q3季报总结：创新出海率先回暖，其他细分静待改善

国投证券医药研究

港股公告掘金 | 乐舒适明日上市富智康集团预期年度财务业绩大幅改善

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/01276/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":71.7,"timestamp":1763436790318,"preClose":71.1,"halted":0,"volume":1561816,"delay":0,"floatShares":258000000,"shares":6637000000,"eps":1.0936272794432134,"marketStatus":"交易中","change":0.6,"latestTime":"11-18 11:33:23","open":70.9,"high":72.6,"low":70.7,"amount":112512834,"amplitude":0.026723,"askPrice":71.75,"askSize":36400,"bidPrice":71.7,"bidSize":46600,"shortable":3,"etf":0,"ttmEps":1.2688351186282516,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1763438400000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":71.1,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"volumeRatio":1.113516,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":62.05,"timestamp":1763436598000,"preClose":61.8,"halted":0,"volume":12771600,"delay":0,"premium":"+5.66"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"8.37%","roe":"14.34%","lyrEps":1.093627,"volumeRatio":1.113516,"shares":6637000000,"dividePrice":0,"high":72.6,"amplitude":0.026723,"preClose":71.1,"low":70.7,"week52Low":52.5,"pbRate":"7.31","psRate":"14.04","week52High":95.2,"institutionHeld":0,"latestPrice":71.7,"committee":0.122892,"eps":1.0936272794432134,"divideRate":0,"volume":1561816,"delay":0,"ttmEps":1.2688351186282516,"open":70.9,"prevYearClose":44.05,"prevWeekClose":71.6,"prevMonthClose":75.2,"prevQuarterClose":88.8,"fiveDayClose":70.85,"twentyDayClose":79.25,"sixtyDayClose":77.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null},{"date":"2025-08-21","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5714,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1760716800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2025-11-14","current":56.046592,"percent":0.385246,"low":50.027905,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"high":65.582363,"avg":57.773326,"sd":4.626144,"marketCap":457058673340.29},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29}],"updateTime":1763410594016},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2582366645","title":"医药领域，这些潜力赛道即将爆发！","url":"https://stock-news.laohu8.com/highlight/detail?id=2582366645","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582366645?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 19:13","pubTimestamp":1762859617,"startTime":"0","endTime":"0","summary":"2025年，默克宣布与加拿大AI制药公司Variational AI达成协议，潜在交易总价值达3.49亿美元，默克将利用其AI药物发现平台设计和优化针对两个未公开靶点的小分子候选药物。礼来的Orforglipron在全球口服小分子中进展最快，预计今年年底递交上市申请（图3），国内企业如恒瑞医药、华东医药、闻泰科技等也在该领域积极布局，部分管线已进入临床中后期，展现出较强的出海潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111200654a6f1f725&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z4B17.USD","09887","BK4187","BK4007","BK4006","06998","IE00B7SZL793.SGD","IE0031619046.USD","NVO","BK4532","02105","LU2065731478.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU1093756168.USD","IE00B66KJ199.SGD","IE00BZ1G4Q59.USD","BK4585","LU0154236417.USD","BK4588","01276","LU0963586101.USD","BK4599","CRS"],"gpt_icon":1},{"id":"2582940350","title":"创新药龙头领跑与新锐突围的双重奏｜三季报专题","url":"https://stock-news.laohu8.com/highlight/detail?id=2582940350","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582940350?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 18:01","pubTimestamp":1762855281,"startTime":"0","endTime":"0","summary":"《投资者网》蔡俊重新在上行周期的创新药行业，进入上市公司密集发布三季报的时间。其中，创新药收入占比达58%，大单品PD-1抑制剂卡瑞利珠单抗的销售额超50亿元。同时，该企业的研发取得双重突破。今年上半年，翰森制药的收入74.34亿元，同比增长14.3%，创新药与合作产品收入达61.45亿元。更令市场感兴趣的是，其连续两个季度实现盈利，第三季度经调整利润6563万美元。截至目前，贝达药业、艾力斯的市值分别约230亿元、450亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111118261597625083&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111118261597625083&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5MMRT66.SGD","LU2488822045.USD","LU0348766576.USD","LU0417516571.SGD","06978","LU0561508036.HKD","03692","LU2399975544.HKD","LU0348784397.USD","LU0417516902.SGD","LU0540923850.HKD","IE00B543WZ88.USD","LU0417516738.SGD","LU1794554557.SGD","LU0348825331.USD","LU0348783233.USD","LU1961090484.USD","LU2476274720.SGD","BK1161","06160","01276","LU0348827113.USD","LU2778985437.USD","09926","LU1720050803.USD","LU0348767384.USD","IE00BPRC5H50.USD","BK1574","LU0348735423.USD","LU0634319403.HKD","LU2476274308.USD"],"gpt_icon":0},{"id":"2582359717","title":"智通AH统计|11月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2582359717","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582359717?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:47","pubTimestamp":1762850821,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月11日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为847.37%、263.84%、260.26%；宁德时代、招商银行、恒瑞医药分列AH溢价率末三位，溢价率分别为-14.64%、-1.23%、4.67%。其中弘业期货、浙江世宝、中石化油服的偏离值位居前三，分别为24.14%、21.73%、21.45%；另外，安德利果汁、中国人寿、赣锋锂业的偏离值位居后三，分别为-18.30%、-15.88%、-15.49%。　　前十大AH股溢价率排行。　　股票名称H股(港元)A股溢价率↓偏离值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251111/31784856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02359","LU0211977185.USD","BK1202","03750","BK1129","03678","06869","02218","06826","01919","01057","01108","LU1242518857.USD","03143","LU0328353924.USD","LU0072913022.USD","01349","00598","03968","06031","06178","00187","00883","159982","02899","399300","02338","IE00B3M56506.USD","LU0880133367.SGD","01276","LU2097828474.EUR","02628","BK1610","IE00BZ08YS42.EUR","80883","02883","LU0972618739.USD","01138","01988","00042","LU1064131003.USD","03606","01812","LU1282649141.HKD","00670","01033","00916","00300"],"gpt_icon":1},{"id":"2582334775","title":"每日卖空追踪 | 恒瑞医药 11月11日卖空量成交45.76万股，卖空比例为15.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582334775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582334775?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:30","pubTimestamp":1762849819,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间11月11日，跌0.49%，卖空量成交45.76万股，较上一交易日减少46.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116323097621a9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116323097621a9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU0359201612.USD","LU1023057109.AUD","01276","BK1191","LU2543165471.USD","LU0359202008.SGD"],"gpt_icon":0},{"id":"2582357420","title":"透视81家创新药企三季报：亏损收窄医保放量BD增长释放什么信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2582357420","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582357420?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 15:35","pubTimestamp":1762846544,"startTime":"0","endTime":"0","summary":"整体来看，81家A股创新药上市公司归母净利润实现同比增长，增幅达13.84%。数据显示，近年来，中国创新药企业国际授权合作数量不断增加。截至10月21日，2025年中国创新药对外许可交易115起，总金额1012.4亿美元，远超2024年全年519亿美元。11月3日，为期五天的2025年国家医保谈判收官，今年的国家医保谈判，在延续医保目录常规调整机制的基础上，首次引入商保创新药目录新机制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111153610a6f15fdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111153610a6f15fdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","09887","BK1574","09969","06978","01276","BK1161","02509"],"gpt_icon":0},{"id":"2582873376","title":"从政策优化到价值发现：医药产业升级下的投资新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2582873376","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582873376?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 18:06","pubTimestamp":1762769180,"startTime":"0","endTime":"0","summary":"近期观点1.集采政策显示积极信号2.非肿瘤领域成为研发新焦点3.复杂技术平台迎来黄金发展期4.线上零售渠道价值凸显5.出海与CXO全球化构成双重驱动投资建议基于对当前医药产业结构性转型的深入分析，投资布局应重点关注以下三条高景气产业链：一是CXO，在产业全球化与研发外包深化的趋势下，其复合增长率显著高于全球行业平均水平，头部企业通过完善的全球网络与技术创新，持续赋能医药研发全链条。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110180630a4970377&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110180630a4970377&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","LU0359201885.HKD","BK1191","LU0359202008.SGD","LU1023057109.AUD","LU2543165471.USD","01276","03347"],"gpt_icon":0},{"id":"2582820924","title":"宏观经济点评：有色与中下游制造带动PPI同比回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2582820924","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582820924?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 18:05","pubTimestamp":1762769159,"startTime":"0","endTime":"0","summary":"事件：10月CPI同比0.2%，预期-0.1%，前值-0.3%；PPI同比-2.1%，预期-2.3%，前值-2.3%。有色与中下游制造业价格改善，带动PPI同比回升10月PPI同比较前值回升0.2个百分点至-2.1%；环比较前值回升0.1个百分点至0.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018060394fb2849&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111018060394fb2849&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0211977185.USD","LU0345780521.USD","01276","LU0164880469.USD","LU0164865239.USD","LU0828237940.HKD","SG9999004220.SGD","LU0828237510.HKD","LU0061477393.USD","LU0463099449.HKD","LU1720050803.USD","HK0000320264.USD","LU0140636845.USD","00914","LU1769817096.USD","LU0588546209.SGD","LU0149721374.USD","LU0348827113.USD","LU1188198961.HKD","BK1544","LU0228659784.USD","LU0456854461.SGD","LU1719994722.HKD","LU0266512473.USD","LU1769817179.HKD","LU1481107354.HKD","LU0106252389.USD","LU0327786744.USD","LU0181495838.USD","LU0572944931.SGD","LU2097828474.EUR","02899","LU0096374516.USD","LU0326950275.SGD","BK1592","LU0266512127.USD","LU2399975544.HKD","LU0370786039.SGD","BK1594","LU0737861699.HKD","LU1242518931.SGD","LU2039709279.SGD","LU0048580855.USD","LU0417516902.SGD","LU0328353924.USD","HK0000306685.HKD","LU0307460666.USD","LU0417516738.SGD","02600","LU1224709979.USD","LU0039217434.USD","LU0821914370.USD","LU1770034418.SGD"],"gpt_icon":0},{"id":"2582826823","title":"恒瑞医药(01276)11月10日斥资366.84万元回购6万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2582826823","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582826823?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 16:54","pubTimestamp":1762764863,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，于2025年11月10日该公司斥资人民币366.84万元回购6万股A股，回购价格为每股人民币61.00-61.31元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1997244956.HKD","BK1191","LU2097828805.USD","LU1580142542.USD","LU1064130708.USD","LU2543165471.USD","BK0028","LU0359201885.HKD","LU2580892862.HKD","LU1146622755.USD","BK0183","LU1969619763.USD","LU2488822045.USD","BK0196","LU1997245177.USD","399300","LU2097828714.EUR","LU2097828557.USD","BK0239","LU2097828631.EUR","LU1328615791.USD","BK0012","LU1655091616.SGD","LU0405327494.USD","LU0405327148.USD","LU1255011170.USD","LU0359202008.SGD","LU1820825898.SGD","LU1997245094.SGD","BK0188","LU1781817850.SGD","600276","LU2148510915.USD","LU2580892789.USD","LU2097828474.EUR","01276","LU1064131003.USD","LU2328871848.SGD","LU2495084118.USD","LU0359201612.USD","BK0060","159982","LU2289578879.USD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2582780138","title":"每日卖空追踪 | 恒瑞医药 11月10日卖空量成交27.96万股，卖空比例为8.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582780138","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582780138?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 16:30","pubTimestamp":1762763418,"startTime":"0","endTime":"0","summary":"恒瑞医药北京时间11月10日，涨1.79%，卖空量成交27.96万股，较上一交易日减少72.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110163250a6ef0074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110163250a6ef0074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201885.HKD","LU0359201612.USD","LU0359202008.SGD","LU1023057109.AUD","LU2543165471.USD","01276","BK1191"],"gpt_icon":0},{"id":"2582823396","title":"智通AH统计|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582823396?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 16:15","pubTimestamp":1762762506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月10日收盘，东北电气、弘业期货、中石化油服分列AH溢价率前三位，溢价率分别为864.29%、261.08%、253.16%；招商银行、恒瑞医药、美的集团分列AH溢价率末三位，溢价率分别为-0.54%、4.02%、6.04%。其中均胜电子、赛力斯、东北电气的偏离值位居前三，分别为85.91%、43.66%、30.58%；另外，中国人寿、中海油田服务、赣锋锂业的偏离值位居后三，分别为-14.16%、-12.32%、-11.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00300","01349","01812","399300","06826","BK1592","02359","HYDD.SI","02218","00670","01919","00042","06869","03606","00699","02883","06030","06031","03678","02628","IE00BZ08YT58.USD","002594","81211","01988","02899","03968","00187","06178","00883","LU1861219969.SGD","03143","BYDDY","01033","80883","00895","01057","LU1880383440.USD","01055","159982","IE00BD6J9T35.USD","01108","LU0315179316.USD","01880","01276","LU0043850808.USD"],"gpt_icon":1},{"id":"2582846287","title":"中邮证券-医药生物行业周报：自免口服药物市场存在供需错配，关注NME带来的积极转变-251110","url":"https://stock-news.laohu8.com/highlight/detail?id=2582846287","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582846287?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 12:02","pubTimestamp":1762747320,"startTime":"0","endTime":"0","summary":"本周主题本周我们探讨自免领域的口服药物市场价值。自免药物的口服需求庞大，现有疗法存在供需错配。参考NatureReviews，2023年银屑病整体市场为270亿美金，其中口服药物为25亿美金，仅占9%。药物市场主要由IL-23、IL-17和TNF等生物类抑制剂占据。从需求端来看，75%接受注射疗法的病人存在转换为口服的意愿。恒生医疗保健指数下跌2.39%，板块整体跑输恒生指数3.68pct。在恒生12个一级子行业中，医疗保健行业周涨跌幅排名为第12位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110125601a49646b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110125601a49646b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09926","IE00B5MMRT66.SGD","LU0348783233.USD","LU0417516738.SGD","LU0417516571.SGD","LU0561508036.HKD","09887","BK1161","LU0348766576.USD","03759","LU1720050803.USD","LU0417516902.SGD","LU2488822045.USD","02509","06978","BK1574","LU0348827113.USD","LU2399975544.HKD","LU1794554557.SGD","LU2476274308.USD","LU0348825331.USD","LU0348767384.USD","IE00B543WZ88.USD","LU0348735423.USD","LU0634319403.HKD","LU0348784397.USD","09606","IE00BPRC5H50.USD","02157","01276","LU2778985437.USD","LU0540923850.HKD","LU2476274720.SGD","LU1961090484.USD"],"gpt_icon":0},{"id":"2582843389","title":"69岁药企“老兵”海正药业再战江湖，跨界医美能否焕发第二春？","url":"https://stock-news.laohu8.com/highlight/detail?id=2582843389","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582843389?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 11:19","pubTimestamp":1762744741,"startTime":"0","endTime":"0","summary":"作为有着69年历史的国有控股药企，海正药业近年来受带量采购政策冲击、高管团队更迭等因素影响，公司业绩一度陷入低谷。不过，海正药业正试图通过跨界医美、发力合成生物学等动作打开新增长空间。这一亮眼表现，与海正药业同期深陷亏损的困境形成了鲜明对比。今年8月26日，海正药业发布公告称，拟以3.9亿元的挂牌底价出售省医药公司100%股权，预计每年减少30多亿元营收。2012年至2015年，他加入海正药业，担任海正辉瑞首席执行官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1762477054476018735","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU0321505439.SGD","IE000M9KFDE8.USD","LU1057294990.SGD","LU2543165471.USD","BK4534","IE00BLSP4452.SGD","LU0225771236.USD","LU1894683264.USD","BK4568","SG9999001176.SGD","LU0359202008.SGD","IE00BBT3K403.USD","LU1066053197.SGD","SG9999011175.SGD","IE00BLSP4239.USD","LU0234572021.USD","01276","LU0359201612.USD","LU0058720904.USD","LU1023057109.AUD","LU1883839398.USD","LU0225284248.USD","SG9999013999.USD","LU0306806265.USD","LU0122379950.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999002232.USD","LU1894683348.USD","BK1191","LU0868494617.USD","LU0321505868.SGD","BK4592","LU0306807586.USD","LU1023059063.AUD","01477","BK4007","BK4550","LU0456855351.SGD","LU1066051498.USD","BK1574","BK4599","LU0289739699.SGD","LU0359201885.HKD","BK4585","BK4533","SG9999002224.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2582504810","title":"报告：全球区域化趋势已基本形成，长三角这项能力需加强","url":"https://stock-news.laohu8.com/highlight/detail?id=2582504810","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582504810?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 10:07","pubTimestamp":1762740455,"startTime":"0","endTime":"0","summary":"经过近一个时间段供应链的调整，整个供应链的去集中化以及近岸、回流的趋势越发明显，全球区域化、板块化的趋势已经基本形成。其中，上海及长三角的产业效率提升最快，国际国内的市场表现是当前支撑国际竞争力的重要支柱，产业集聚度和投入服务化能力是近年来政策投入的重点，效果将在后期集中体现，但新技术的产业转化能力还需加强。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110100922a6ee2941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110100922a6ee2941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1993786604.SGD","01276","BK1610","LU1960683339.HKD","03750","BK1116","LU1807302812.USD","00981"],"gpt_icon":1},{"id":"2582823657","title":"医药行业周报：AI+医疗发展方向落地，2030年实现基层AI诊疗全覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823657","media":"西南证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582823657?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 10:05","pubTimestamp":1762740356,"startTime":"0","endTime":"0","summary":"投资要点行情回顾：本周医药生物指数下跌2.4%，跑输沪深300指数3.22个百分点，行业涨跌幅排名第29。“AI+医疗”发展方向落地，2030年实现基层AI诊疗全覆盖。同时《意见》详细划分了AI+医疗卫生落地的八大领域，包括基层应用、临床诊疗、患者服务中医药、公共卫生、科研教学、行业治理、健康产业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110100611a495e8f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110100611a495e8f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","LU0359202008.SGD","01276","LU0359201885.HKD","BK1191","LU2543165471.USD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2582658823","title":"核心50ETF开盘涨0.47%，重仓股东方财富跌0.08%，恒瑞医药跌0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582658823","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582658823?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 09:36","pubTimestamp":1762738560,"startTime":"0","endTime":"0","summary":"11月10日，核心50ETF（560650）开盘涨0.47%，报1.062元。其重仓股表现各异，东方财富跌0.08%，恒瑞医药跌0.02%，阳光电源涨1.09%，迈瑞医疗跌0.14%，豪威集团涨0.10%，万华化学涨1.42%，福耀玻璃跌0.13%，天孚通信涨1.15%，同花顺跌0.31%，思源电气涨0.00%。该ETF业绩比较基准为中证企业核心竞争力50指数收益率，由民生加银基金管理有限公司管理，基金经理为周帅，自2022年6月13日成立以来回报为5.72%，近一个月回报为-2.46%。市场有风险，投资需谨慎，本文信息仅作参考，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110094447975f1e9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110094447975f1e9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2543165471.USD","BK1191","LU0359202008.SGD","LU0359201612.USD","01276","LU0359201885.HKD","LU1023057109.AUD"],"gpt_icon":0},{"id":"2582849703","title":"中国创新药“生死局”：一边是IPO，一边是ICU","url":"https://stock-news.laohu8.com/highlight/detail?id=2582849703","media":"腾讯新闻潜望","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582849703?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 07:25","pubTimestamp":1762730700,"startTime":"0","endTime":"0","summary":"中国创新药资本市场发展不过十年，但已饱尝周期的甜头与苦涩。再加上创新药出海频传大额交易，医药板块迎来强势反弹，恒生生物科技指数年初至今的升幅一度超过100%。“现在评估Pre-IPO项目，一定会先看CFO是谁。”医药魔方数据显示，2024年中国创新药一级市场融资额仅有2021年的五分之一，IPO次数和募资金额也创十年新低。加上中国创新药同质化严重，一个热门靶点可能有上百家公司在争夺，都在争取几家顶尖肿瘤医院做临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110072849975ee55d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110072849975ee55d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","09887","09969","06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2582890572","title":"A+H板块持续扩容 AH溢价呈现分化","url":"https://stock-news.laohu8.com/highlight/detail?id=2582890572","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582890572?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 00:36","pubTimestamp":1762706218,"startTime":"0","endTime":"0","summary":"本报记者毛艺融今年以来，“A+H”板块持续扩容。Wind资讯数据显示，截至11月9日，年内已有16家A股公司在港上市，首发募资额累计1040亿港元，占据港股市场全年首发募资额的48%。截至11月9日，这些新上市H股表现分化，A股溢价仍是主流，但呈现分化趋势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511103559070313.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1960683339.HKD","BK1610","BK1191","LU0359202008.SGD","LU1023057109.AUD","LU1807302812.USD","LU2543165471.USD","LU0359201612.USD","LU0359201885.HKD","01276","BK1116","LU1993786604.SGD","03750"],"gpt_icon":1},{"id":"2582823650","title":"恒瑞医药：“创新+出海”快速推动全球化","url":"https://stock-news.laohu8.com/highlight/detail?id=2582823650","media":"东方证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582823650?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 00:00","pubTimestamp":1762704000,"startTime":"0","endTime":"0","summary":"核心观点创新药放量叠加出海提速，驱动业绩高质量增长。Q3单季度实现营收74.27亿元，同比+12.72%，归母净利润13.01亿元，同比+9.53%。公司通过BD交易与自研出海双路径加速全球化落地，前三季度海外授权首付款已超8亿美元。我们认为，凭借公司强大的自主研发实力，未来创新药成果有望持续出海，引领国产创新药出海浪潮。风险提示创新药研发不及预期的风险，创新药销售不及预期的风险，仿制药进入集采的风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110142127975f9719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110142127975f9719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359202008.SGD","LU2543165471.USD","LU0359201612.USD","01276","LU0359201885.HKD","BK1191","LU1023057109.AUD"],"gpt_icon":0},{"id":"2582989207","title":"【国投证券 | 医药】医药板块25Q3季报总结：创新出海率先回暖，其他细分静待改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2582989207","media":"国投证券医药研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582989207?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 21:53","pubTimestamp":1762696384,"startTime":"0","endTime":"0","summary":"2025Q3单季度化学原料药板块营收同比下降3.25%，归母净利润同比下降32.42%，扣非净利润同比下降37.82%。医疗器械：2025Q3 单季度来看，医疗器械板块整体营收同比增长1.38%，归母净利润同比减少14.31%，扣非净利润同比减少14.29%，毛利率为54.32%，扣非净利率为15.55%。在国投证券医药分类下，除去医药主业不突出的转型类公司。其中，医药行业的归母净利润同比下滑1.59%，位居28个基期非亏损的申万一级行业中的第18位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109220019a494d616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251109220019a494d616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","09939","LU2097828714.EUR","LU2097828805.USD","LU2328871848.SGD","LU2097828474.EUR","BK1589","LU0455707207.USD","LU2488822045.USD","BK1574","LU0502904849.HKD","01276","BK1161","LU1969619763.USD","LU2097828631.EUR","01801","BK1515","LU2097828557.USD","BK1583","HK0000165453.HKD"],"gpt_icon":0},{"id":"2582950894","title":"港股公告掘金 | 乐舒适明日上市 富智康集团预期年度财务业绩大幅改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2582950894","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582950894?lang=zh_cn&edition=fundamental","pubTime":"2025-11-09 19:58","pubTimestamp":1762689534,"startTime":"0","endTime":"0","summary":"【重大事项】乐舒适(02698):香港公开发售获1813.77倍认购 预计11月10日上市中伟新材(02579)11月7日至11月12日招股 预计11月17日上市百利天恒(02615)11月7日至11月12日招股 预计11月17日上市昊海生物科技(06826)拟7400万元收购深圳市新产业眼科新技术有限公司余下20%股权维立志博-B(09887)获纳入MSCI全球小型股指数恒瑞医药(01276)：","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1160","LU0359201885.HKD","BK1612","BK1161","BK1531","BK1104","BK1167","LU0359201612.USD","BK1191","LU1023057109.AUD","09887","BK1508","LU0359202008.SGD","02698","LU2543165471.USD","02038","01276","BK1526","00434","BK1504"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}